Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Siga Technologies Share Holder Equity 2010-2023 | SIGA

Siga Technologies share holder equity from 2010 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
  
Siga Technologies Annual Share Holder Equity
(Millions of US $)
2023 $197
2022 $170
2021 $174
2020 $130
2019 $98
2018 $103
2017 $-323
2016 $-287
2015 $-284
2014 $-247
2013 $17
2012 $28
2011 $41
2010 $12
2009 $7
Siga Technologies Quarterly Share Holder Equity
(Millions of US $)
2023-12-31 $197
2023-09-30 $124
2023-06-30 $124
2023-03-31 $162
2022-12-31 $170
2022-09-30 $173
2022-06-30 $140
2022-03-31 $168
2021-12-31 $174
2021-09-30 $107
2021-06-30 $117
2021-03-31 $123
2020-12-31 $130
2020-09-30 $113
2020-06-30 $94
2020-03-31 $88
2019-12-31 $98
2019-09-30 $103
2019-06-30 $103
2019-03-31 $106
2018-12-31 $103
2018-09-30 $52
2018-06-30 $-341
2018-03-31 $-335
2017-12-31 $-323
2017-09-30 $-313
2017-06-30 $-303
2017-03-31 $-296
2016-12-31 $-287
2016-09-30 $-313
2016-06-30 $-304
2016-03-31 $-295
2015-12-31 $-284
2015-09-30 $-265
2015-06-30 $-259
2015-03-31 $-253
2014-12-31 $-247
2014-09-30 $-228
2014-06-30 $12
2014-03-31 $14
2013-12-31 $17
2013-09-30 $19
2013-06-30 $23
2013-03-31 $26
2012-12-31 $28
2012-09-30 $32
2012-06-30 $34
2012-03-31 $38
2011-12-31 $41
2011-09-30 $46
2011-06-30 $43
2011-03-31 $11
2010-12-31 $12
2010-09-30 $8
2010-06-30 $4
2010-03-31 $7
2009-12-31 $7
2009-09-30 $-11
2009-06-30 $-13
2009-03-31 $-6
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.562B $0.140B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.263B 32.23
Chugai Pharmaceutical (CHGCY) Japan $51.982B 23.24
Takeda Pharmaceutical (TAK) Japan $42.124B 8.53
Merck (MKGAF) Germany $23.587B 22.87
Astellas Pharma (ALPMY) Japan $17.518B 27.66
Sandoz Group AG (SDZNY) Switzerland $15.512B 0.00
Neurocrine Biosciences (NBIX) United States $14.281B 39.09
Shionogi (SGIOY) Japan $13.629B 11.85
United Therapeutics (UTHR) United States $12.075B 12.87
Catalent (CTLT) United States $9.999B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.716B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.965B 7.66
Revolution Medicines (RVMD) United States $6.433B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.491B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.628B 0.00
Alpine Immune Sciences (ALPN) United States $4.456B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.094B 0.00
Summit Therapeutics (SMMT) United States $3.166B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.105B 0.00
Corcept Therapeutics (CORT) United States $2.867B 25.98
PTC Therapeutics (PTCT) United States $2.610B 0.00
Dyne Therapeutics (DYN) United States $2.512B 0.00
Indivior (INDV) United States $2.391B 11.33
Recursion Pharmaceuticals (RXRX) United States $2.232B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.083B 11.84
Evotec AG (EVO) Germany $1.946B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.937B 18.85
Fusion Pharmaceuticals (FUSN) Canada $1.825B 0.00
Ardelyx (ARDX) United States $1.813B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.804B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Avadel Pharmaceuticals (AVDL) Ireland $1.532B 0.00
Soleno Therapeutics (SLNO) United States $1.526B 0.00
Pacira BioSciences (PCRX) United States $1.467B 13.94
Xencor (XNCR) United States $1.385B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.335B 0.00
4D Molecular Therapeutics (FDMT) United States $1.326B 0.00
Cronos Group (CRON) Canada $1.154B 0.00
Enliven Therapeutics (ELVN) United States $1.120B 0.00
Collegium Pharmaceutical (COLL) United States $1.102B 6.59
Ironwood Pharmaceuticals (IRWD) United States $1.039B 16.19
Cassava Sciences (SAVA) United States $1.034B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.012B 0.00
Ocular Therapeutix (OCUL) United States $0.971B 0.00
USANA Health Sciences (USNA) United States $0.924B 15.11
ARS Pharmaceuticals (SPRY) United States $0.882B 0.00
ProKidney (PROK) United States $0.869B 0.00
Relay Therapeutics (RLAY) United States $0.864B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.823B 0.00
Sage Therapeutics (SAGE) United States $0.723B 0.00
Lyell Immunopharma (LYEL) United States $0.709B 0.00
Silence Therapeutics (SLN) United Kingdom $0.687B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.656B 0.00
Savara (SVRA) United States $0.652B 0.00
Altimmune (ALT) United States $0.631B 0.00
Exscientia (EXAI) United Kingdom $0.620B 0.00
Harrow (HROW) United States $0.572B 0.00
Verve Therapeutics (VERV) United States $0.536B 0.00
OmniAb (OABI) United States $0.533B 0.00
Bioventus (BVS) United States $0.525B 20.09
KalVista Pharmaceuticals (KALV) United States $0.509B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.491B 0.00
Esperion Therapeutics (ESPR) United States $0.491B 0.00
Heron Therapeutics (HRTX) United States $0.485B 0.00
Korro Bio (KRRO) United States $0.475B 0.00
Larimar Therapeutics (LRMR) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.467B 0.00
Lexeo Therapeutics (LXEO) United States $0.462B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.388B 0.00
Tourmaline Bio (TRML) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.378B 71.25
Nanobiotix S.A (NBTX) France $0.342B 0.00
Nektar Therapeutics (NKTR) United States $0.331B 0.00
Fractyl Health (GUTS) United States $0.320B 0.00
Xeris Biopharma Holdings (XERS) United States $0.299B 0.00
Aquestive Therapeutics (AQST) United States $0.299B 0.00
Black Diamond Therapeutics (BDTX) United States $0.295B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 18.58
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.277B 0.00
Metagenomi (MGX) United States $0.262B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Pyxis Oncology (PYXS) United States $0.246B 0.00
Aldeyra Therapeutics (ALDX) United States $0.243B 0.00
Akebia Therapeutics (AKBA) United States $0.239B 0.00
Eliem Therapeutics (ELYM) United States $0.238B 0.00
Prelude Therapeutics (PRLD) United States $0.235B 0.00
Conduit Pharmaceuticals (CDT) United States $0.217B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
Avita Medical (RCEL) United States $0.204B 0.00
Century Therapeutics (IPSC) United States $0.203B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Galectin Therapeutics (GALT) United States $0.195B 0.00
Adherex Technologies (FENC) United States $0.195B 237.33
Acrivon Therapeutics (ACRV) United States $0.194B 0.00
Telomir Pharmaceuticals (TELO) United States $0.183B 0.00
VAXART, INC (VXRT) United States $0.180B 0.00
CytoDyn (CYDY) United States $0.178B 0.00
Incannex Healthcare (IXHL) Australia $0.176B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.174B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.172B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Cardiol Therapeutics (CRDL) Canada $0.161B 0.00
Elite Pharmaceuticals (ELTP) United States $0.148B 13.90
OptiNose (OPTN) United States $0.146B 0.00
Context Therapeutics (CNTX) United States $0.135B 0.00
Karyopharm Therapeutics (KPTI) United States $0.134B 0.00
Regulus Therapeutics (RGLS) United States $0.131B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.32
FibroGen (FGEN) United States $0.123B 0.00
Citius Pharmaceuticals (CTXR) United States $0.121B 0.00
PMV Pharmaceuticals (PMVP) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.108B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
ProPhase Labs (PRPH) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.097B 4.43
SCYNEXIS (SCYX) United States $0.091B 1.28
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Jaguar Animal Health (JAGX) United States $0.079B 0.00
Protara Therapeutics (TARA) United States $0.077B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Tempest Therapeutics (TPST) United States $0.072B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.071B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.057B 0.00
Inotiv (NOTV) United States $0.056B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Nutriband (NTRB) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.043B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Lipocine (LPCN) United States $0.031B 0.00
DURECT (DRRX) United States $0.029B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
Lyra Therapeutics (LYRA) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Talphera (TLPH) United States $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.75
GlycoMimetics (GLYC) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Clever Leaves Holdings (CLVR) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.96
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.44